TechNavio recognizes the following companies as the key players in the Global Cardiovascular Drugs Market: Pfizer Inc., Bristol-Myers Squibb Co, AstraZeneca plc, Novartis AG, Merck & Co. Inc. and Sanofi S.A.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”In the last few years, the Healthcare industry has witnessed phenomenal growth in the APAC region. Emerging economies such as the APAC region, Eastern Europe, and Latin America hold vast growth potential. These regions are under-equipped to address the increase in the incidence of CVDs in the region. However, the increase in the incidence of CVDs and instances of patients frequently enduring long waits for therapeutic treatments are forcing healthcare organizations in the region to opt for cardiovascular drugs. Moreover, there has been substantial investment to initiate a significant number of projects in R&D across the developing countries. Hence, healthcare organizations in developing regions such as the APAC region and the Middle East are opting for cardiovascular drugs in accordance with the demand in specific countries. The increasing demand for cardiovascular drugs in the developing countries is boosting the growth of the Global Cardiovascular Drugs market.”
According to the report, one of the major growth factors driving the Global Cardiovascular Drugs market is the increase in the prevalence of cardiovascular patients worldwide. Therapeutic drugs are among the remedies for CVDs, and hence healthcare organizations are opting for cardiovascular drugs for treatments.
Further, the report states that one of the major challenges is the over-dependency of the market on the US, because the US holds the majority of the market share.
The report also includes a discussion on other prominent companies operating in this market, such as Abbott Laboratories, Forest Laboratories Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Daiichi Sankyo Co. Ltd., GlaxoSmithKline plc, Solvay SA, Takeda Pharmaceutical Co. Ltd., and The Medicines Company.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-cardiovascular-drugs-market-2012…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global Cardiovascular Drugs Market 2012-2016
